Early Treatment of Migraine With Rizatriptan: A Placebo‐Controlled Study

Abstract

Rizatriptan is significantly more likely than placebo to produce a pain-free response within 2 hours when the drug is administered early in the migraine attack, when pain is mild rather than moderate or severe.